VYNE Therapeutics (VYNE) Interest & Investment Income (2017 - 2020)
VYNE Therapeutics (VYNE) posted Interest & Investment Income of $4000.0 for Q3 2020, down 99.29% on a QoQ basis from $564000.0 in Q2 2020, and down 98.95% year-over-year from $381000.0 in Q4 2019.
VYNE Therapeutics (VYNE) Interest & Investment Income (2017 - 2020) Analysis & Trends
VYNE Therapeutics' Interest & Investment Income history runs 4 years deep, the most recent figure standing at $4000.0 for Q3 2020.
- Quarterly Interest & Investment Income fell 98.95% year-over-year to $4000.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $31000.0 (down 97.77% YoY) and the FY2019 annual result came in at $120000.0, up 366.67% from the prior year.
- Interest & Investment Income was $4000.0 for Q3 2020 at VYNE Therapeutics, down from $564000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $728000.0 in Q1 2020 and bottomed at -$1.3 million in Q4 2019.
- A 4-year average of $88000.0 and a median of $8000.0 in 2017 frame the typical range for Interest & Investment Income.
- Peak annual rise in Interest & Investment Income reached 783.02% in 2019, while the deepest fall reached 25400.0% in 2019.
- VYNE Therapeutics' Interest & Investment Income stood at -$36000.0 in 2017, then soared by 113.89% to $5000.0 in 2018, then plunged by 25400.0% to -$1.3 million in 2019, then jumped by 100.32% to $4000.0 in 2020.
- Business Quant data shows VYNE's Interest & Investment Income at $4000.0 in Q3 2020, $564000.0 in Q2 2020, and $728000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 564,000.00 |
| Mar 31, 2020 | 728,000.00 |
| Dec 31, 2019 | -1.27 Mn |
| Sep 30, 2019 | 381,000.00 |
| Jun 30, 2019 | 468,000.00 |
| Mar 31, 2019 | 536,000.00 |
| Dec 31, 2018 | 5,000.00 |
| Sep 30, 2018 | 48,000.00 |
| Jun 30, 2018 | 53,000.00 |
| Mar 31, 2018 | -151,000.00 |
| Dec 31, 2017 | -36,000.00 |
| Sep 30, 2017 | -19,000.00 |
| Jun 30, 2017 | 8,000.00 |
| Mar 31, 2017 | -4,000.00 |